Möchten Sie immer auf dem neuesten Stand bleiben?

Biologic Innovation to Drive Global Ophthalmic Drugs Market Growth at 7.9% CAGR Through 2036, supported by anti-VEGF therapies and AI-enabled imaging.

Dublin, Feb. 24, 2026 (GLOBE NEWSWIRE) -- The "OTC Artificial Tears Market Key Players Analysis, Company Profiles, Strategic Developments, Mergers, Product Innovations, Revenue Insights, and Future...

Dublin, Feb. 24, 2026 (GLOBE NEWSWIRE) -- The "Cataract Surgery Devices Market Companies Analysis, Company Profiles, Strategic Developments, Mergers, Product Innovations, Revenue Insights, and...

Dublin, Feb. 18, 2026 (GLOBE NEWSWIRE) -- The "Glaucoma - Competitive Landscape, 2026" has been added to ResearchAndMarkets.com's offering. The report provides a thorough analysis of over 100...

BRISBANE, Calif., Feb. 17, 2026 (GLOBE NEWSWIRE) -- Annexon, Inc. (Nasdaq: ANNX), a biopharmaceutical company advancing the next generation platform of targeted immunotherapies aimed at...

Dublin, Feb. 06, 2026 (GLOBE NEWSWIRE) -- The "Ophthalmology Devices Market - Global Forecast 2026-2032" report has been added to ResearchAndMarkets.com's offering. In 2025, the ophthalmology...

Dublin, Feb. 04, 2026 (GLOBE NEWSWIRE) -- The "Ophthalmic Equipment Market by Technology, Product Type, End User - Global Forecast to 2030" has been added to ResearchAndMarkets.com's offering. ...

Dublin, Feb. 03, 2026 (GLOBE NEWSWIRE) -- The "United States Ophthalmic Viscoelastic Devices (OVD) Market Outlook to 2033 - Cohesive OVD, Dispersive OVD and Viscoadaptive OVD" report has been added...

Chicago, Jan. 27, 2026 (GLOBE NEWSWIRE) -- The global dry eye treatment devices market was valued at 461.01 million in 2024 and is expected to reach US$ 898.78 million by 2033, growing at a CAGR of...

Chicago, Jan. 22, 2026 (GLOBE NEWSWIRE) -- According to recent data from Astute Analytica, the global ophthalmic devices market was valued at US$ 47.28 billion in 2024 and is forecast to reach US$...